Bio-computing takes a leap with 3D brain cell devices. Google's $40B Anthropic investment fuels the AI hardware race, while DeepSeek's new model closes performance gaps. Plus, AI-designed drugs from a DeepMind spinoff enter human trials.
Bio-computing takes a leap with 3D brain cell devices. Google's $40B Anthropic investment fuels the AI hardware race, while DeepSeek's new model closes performance gaps. Plus, AI-designed drugs from a DeepMind spinoff enter human trials.